NovoPedics
James Golubieski is President of Foundation Venture Capital Group, LLC (FVCG) which uses impact investing to provide pre-seed and seed funding to health-related start-up companies to help them advance toward and through commercialization.
FVCG’s investments are made with the intention to generate positive, measurable social impact with any gains realized from the investments reinvested into research at FVCG’s affiliated organizations. FVCG currently has affiliation agreements with Kessler Foundation, New Jersey Institute of Technology, Princeton University, Rowan University, Rutgers University, and Stevens Institute of Technology.
James works closely with the companies in which Foundation Venture has invested, sits on their Boards, and provides guidance in helping them to develop their businesses toward commercialization.
Previously, James was CFO of Array Medical, Inc., a medical device start-up company that developed a groundbreaking blood test to test platelet function and was subsequently acquired. He also served in various executive roles and board member at Glendale National Bank, Glendale Investment Corp., Glendale Mortgage Services, Inc., and Glendale Bancorp, which was acquired by Mellon Financial. James began his career at KPMG.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
NovoPedics
NovoPedics is developing implantable medical devices designed to relieve pain and restore mobility to patients suffering from severe meniscal injuries and meniscectomies.